angiotensin ii, des-phe(8)- has been researched along with l 158809 in 3 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 137 | 0 | 7 |
| Protein | Taxonomy | angiotensin ii, des-phe(8)- (IC50) | l 158809 (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0015 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.0003 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0002 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, MA; Diz, DI; Tallant, EA | 1 |
| Carretero, OA; Garvin, JL; Ren, Y | 1 |
| Naito, Y; Takada, A; Takada, Y; Urano, T; Yoshida, M | 1 |
3 other study(ies) available for angiotensin ii, des-phe(8)- and l 158809
| Article | Year |
|---|---|
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cells, Cultured; Down-Regulation; Imidazoles; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Regression Analysis; Tetrazoles; Type C Phospholipases | 2001 |
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.
Topics: Afferent Pathways; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Male; Norepinephrine; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrinolytic Agents; Humans; Imidazoles; Peptide Fragments; Plasminogen Activator Inhibitor 1; Tetrazoles; Tissue Plasminogen Activator; Umbilical Veins | 2002 |